Treating mannitol in a saturated solution of mannitol: A novel approach to modify mannitol crystals for improved drug delivery to the lungs

International Journal of Pharmaceutics

Volumn 448, Issue 1, 2013, Pages 58-70

  Kaialy, Waseem ^a,b   Nokhodchi, Ali ^a,c  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Agglomeration; Aggregation; Dry powder inhaler; Mannitol; Surface roughness

Indexed keywords

MANNITOL; SALBUTAMOL SULFATE;

AEROSOL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CRYSTAL; DRUG DELIVERY SYSTEM; IN VITRO STUDY; LOWER RESPIRATORY TRACT; LUNG; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; LUNG; MANNITOL; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POWDERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84875684659     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.03.005     Document Type: Article

References (61)

1. S. Adi, H. Adi, H.K. Chan, Z. Tong, R. Yang, and A. Yu Effects of mechanical impaction on aerosol performance of particles with different surface roughness Powder Technol. 236 2013 164 170
2. P.J. Atkins Dry powder inhalers: an overview Respir. Care 50 2005 1304
3. E. Beach, G. Tormoen, J. Drelich, and R. Han Pull-off force measurements between rough surfaces by atomic force microscopy J. Colloid. Interface Sci. 247 2002 84 99 (Pubitemid 34953468)
4. M.F. Biddiscombe, R. Melchor, V.H.F. Mak, R.J. Marriott, A.J. Taylor, M.D. Short, and S.G. Spiro The lung deposition of salbutamol, directly labelled with technetium-99 m, delivered by pressurised metered dose and dry powder inhalers Int. J. Pharm. 91 1993 111 121 (Pubitemid 23159814)
5. R.D. Braatz Advanced control of crystallization processes Annu. Rev. Contr. 26 2002 87 99 (Pubitemid 35170482)
6. A. Burger, J.O. Henck, S. Hetz, J.M. Rollinger, A.A. Weissnicht, and H. Stöttner Energy/temperature diagram and compression behavior of the polymorphs of d-mannitol J. Pharm. Sci. 89 2000 457 468
7. J.X. Chen, J.K. Wang, J. Ulrich, Q.X. Yin, and L.Z. Xue Effect of solvent on the crystal structure and habit of hydrocortisone Cryst. Growth Des. 8 2008 1490 1494
8. N.Y.K. Chew, and H.K. Chan Use of solid corrugated particles to enhance powder aerosol performance Pharm. Res. 18 2001 1570 1577 (Pubitemid 33022413)
9. R.J. Davey, S.N. Black, D. Logan, S.J. Maginn, J.E. Fairbrother, and D.J.W. Grant Structural and kinetic features of crystal growth inhibition: adipic acid growing in the presence of n-alkanoic acids J. Chem. Soc. Faraday Trans 88 1992 3461 3466
10. R.S. Dhumal, S.V. Biradar, A.R. Paradkar, and P. York Particle engineering using sonocrystallization, Salbutamol sulphate for pulmonary delivery Int. J. Pharm. 368 2009 129 137
11. R.S. Dhumal, S.V. Biradar, A.R. Paradkar, and P. York Ultrasound assisted engineering of lactose crystals Pharm. Res. 25 2008 2835 2844
12. R. Docherty, G. Clydesdale, K. Roberts, and P. Bennema Application of bravais-friedel-donnay-harker, attachment energy and ising models to predicting and understanding the morphology of molecular crystals J. Phys. D 24 1991 89
13. M.J. Donovan, and H.D.C. Smyth Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations Int. J. Pharm. 402 2010 1 9
14. M.P. Flament, P. Leterme, and A. Gayot The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers Int. J. Pharm. 275 2004 201
15. D. Ganderton, and N.M. Kassem Dry powder inhalers Adv. Pharm. Sci. 6 1992 165 191
16. E. Guenette, A. Barrett, D. Kraus, R. Brody, L. Harding, and G. Magee Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design Int. J. Pharm. 380 2009 80
17. P. Hartman, and P.J. Bennema The attachment energy as a habit controlling factor: I. Theoretical considerations Cryst. Growth 49 1980 145 156
18. M.S. Hassan, and R. Lau Inhalation performance of pollen-shape carrier in dry powder formulation: effect of size and surface morphology Int. J. Pharm. 413 2011 93 102
19. P.W.S. Heng, L.W. Chan, and L.T. Lim Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate Chem. Pharm. Bull. 48 2000 393 398 (Pubitemid 30187256)
20. R. Ho, D.A. Wilson, and J.Y.Y. Heng Crystal habits and the variation in surface energy heterogeneity Cryst. Growth Des. 9 2009 4907 4911
21. N. Islam, and M.J. Cleary Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery - a review for multidisciplinary researchers Med. Eng. Phys. 34 2012 409 427
22. N. Islam, P. Stewart, I. Larson, and P. Hartley Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy J. Pharm. Sci. 94 2005 1500 1511 (Pubitemid 41168680)
23. N. Islam, P. Stewart, I. Larson, and P. Hartley Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures J. Pharm. Sci. 93 2004 1030 1038 (Pubitemid 38420412)
24. W. Kaialy, M.D. Ticehurst, and A. Nokhodchi Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate Int. J. Pharm. 423 2012 184 194
25. W. Kaialy, A. Alhalaweh, S.P. Velaga, and A. Nokhodchi Influence of lactose carrier particle size on the aerosol performance of budesonide from a dry powder inhaler Powder Technol. 227 2012 74 85
26. W. Kaialy, H. Larhrib, G.P. Martin, and A. Nokhodchi The effect of engineered mannitol-lactose mixture on dry powder inhaler performance Pharm. Res. 29 2012 2139 2156
27. W. Kaialy, H. Larhrib, M.D. Ticehurst, and A. Nokhodchi Influence of batch cooling crystallization on mannitol physical properties and drug dispersion from dry powder inhalers Cryst. Growth Des. 12 2012 3006 3017
28. W. Kaialy, G.P. Martin, M.D. Ticehurst, P. Royall, M.A. Mohammad, J. Murphy, and A. Nokhodchi Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers AAPS J. 13 2011 30 43
29. W. Kaialy, M.D. Ticehurst, J. Murphy, and A. Nokhodchi Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone J. Pharm. Sci. 100 2011 2665 2684
30. W. Kaialy, A. Alhalaweh, S.P. Velaga, and A. Nokhodchi Effect of carrier particle shape on dry powder inhaler performance Int. J. Pharm. 421 2011 12 23
31. W. Kaialy, M.N. Momin, M.D. Ticehurst, J. Murphy, and A. Nokhodchi Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler Colloid. Surface B. 79 2010 345 356
32. W. Kaialy, G.P. Martin, M.D. Ticehurst, M.N. Momin, and A. Nokhodchi The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient Int. J. Pharm. 392 2010 178 188
33. W. Kaialy, and A. Nokhodchi The use of engineered lactose for improved pulmonary drug delivery Lactose as a Carrier for Inhalation Products 2010 TEFARCO Innova, BioPharma Net Parma, Italy
34. N.M. Kassem, and D. Ganderton The influence of carrier surface on the characteristics of inspirable powder aerosols J. Pharm. Pharmacol. 42 1990 11
35. Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate Int. J. Pharm. 172 1998 179 188 (Pubitemid 28430255)
36. N.R. Labiris, and M.B. Dolovich Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications Br. J. Clin. Pharmacol. 56 2003 588
37. H. Larhrib, G.P. Martin, C. Marriott, and D. Prime The influence of carrier and drug morphology on drug delivery from dry powder formulations Int. J. Pharm. 257 2003 283 296 (Pubitemid 36507054)
38. V.N.P. Le, T.H.H. Thi, E. Robins, and M. Flament Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate AAPS Pharm. Sci. Tech. 13 2012 477 484
39. V. Le, H. Bierend, E. Robins, H. Steckel, and M. Flament Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate Int. J. Pharm. 422 2012 75 82
40. Q. Li, V. Rudolph, and W. Peukert London-van der waals adhesiveness of rough particles Powder Technol. 161 2006 248 255 (Pubitemid 43120480)
41. M.D. Louey, M. Van Oort, and A.J. Hickey Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations Pharm. Res. 21 2004 1207 1213 (Pubitemid 38954205)
42. A. Nokhodchi, W. Kaialy, and M.D. Ticehurst The influence of using carriers with increasing elongation ratios on uniformity, adhesion and in vitro aerosolozation performance of salbutamol sulphate from dry powder inhalers CRS Annual Meeting 30 July-03 August, Maryland, USA 2011
43. G. Pilcer, N. Wauthoz, and K. Amighi Lactose characteristics and the generation of the aerosol Adv. Drug Deliv. Rev. 64 2012 233 256
44. F. Podczeck The influence of particle size distribution and surface roughness of carrier particles on the in vitro properties of dry powder inhalations Aerosol Sci. Technol. 31 1999 301 321 (Pubitemid 32001438)
45. F. Podczeck The relationship between physical properties of lactose monohydrate and the aerodynamic behaviour of adhered drug particles Int. J. Pharm. 160 1998 119 130 (Pubitemid 28059936)
46. H. Schiavone, S. Palakodaty, A. Clark, P. York, and S.T. Tzannis Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers Int. J. Pharm. 281 2004 55 66 (Pubitemid 39024263)
47. B.Y. Shekunov, J.C. Feeley, A.H.L. Chow, H.H.Y. Tong, and P. York Aerosolisation behaviour of micronised and supercritically-processed powders J. Aerosol Sci. 34 2003 553 568 (Pubitemid 38352543)
48. J.N. Staniforth, J.E. Rees, F.K. Lai, and J.A. Hersey Interparticle forces in binary and ternary ordered powder mixes J. Pharm. Phrmacol. 34 1982 141 145 (Pubitemid 12114324)
49. H.D.C. Smyth, and A.J. Hickey Carriers in drug powder delivery: implications for inhalation system design Am. J. Drug Deliv. 3 2005 117 132 (Pubitemid 41018283)
50. H. Steckel, and B.W. Müller In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition Int. J. Pharm. 154 1997 31 37 (Pubitemid 27326817)
51. P. Tang, H.K. Chan, and J.A. Raper Prediction of aerodynamic diameter of particles with rough surfaces Powder Technol. 147 2004 64 78 (Pubitemid 39575132)
52. H. Todo, H. Okamoto, K. Iida, and K. Danjo Effect of additives on insulin absorption from intratracheally administered dry powders in rats Int. J. Pharm. 220 2001 101 110 (Pubitemid 32476846)
53. D. Traini, P.M. Young, F. Thielmann, and M. Acharya The influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulations Drug Dev. Ind. Pharm. 34 2008 992 1001
54. M.C.N. Trovão, A. Cavaleiro, and J.D. Pedrosa de Jesus Preparation of polymorphic crystalline phases of d-mannitol: influence of keggin heteropolyanions Carbohydr. Res. 309 1998 363 366 (Pubitemid 29034650)
55. R.A. Tuli, G.A. George, T.R. Dargaville, and N. Islam Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations Pharm. Res. 29 2012 2445 2455
56. M. Vidgren, P. Paronen, P. Vidgren, P. Vainio, and J. Nuutinen In vivo evaluation of the new multiple dose powder inhaler and the rotahaler using the gamma scintigraphy Acta Pharm. Nord. 2 1990 3 10 (Pubitemid 20168637)
57. P.M. Young, H. Chan, H. Chiou, S. Edge, T.H.S. Tee, and D. Traini The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance J. Pharm. Sci. 96 2007 1331 1341 (Pubitemid 46804584)
58. X.M. Zeng, G.P. Martin, and C. Marriott Particulate Interactions in Dry Powder Formulations for Inhalation 2001 Taylor & Francis London
59. X.M. Zeng, G.P. Martin, C. Marriott, and J. Pritchard The influence of carrier morphology on drug delivery by dry powder inhalers Int. J. Pharm. 200 2000 93 106 (Pubitemid 30177254)
60. X.M. Zeng, G.P. Martin, C. Marriott, and J. Pritchard Crystallization of lactose from carbopol gels Pharm. Res. 17 2000 879 886 (Pubitemid 30666971)
61. Q.T. Zhou, and D.A.V. Morton Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces Adv. Drug Deliv. Rev. 64 2012 275 284